Sinopharm's trial vaccine is one of 140 being developed worldwide - but among the few to enter human trials
The vaccine was developed by Chinese state-owned manufacturer Sinopharm and is being tested on 5,000 volunteers in Abu Dhabi and 15,000 people could eventually be involved.
Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health Abu Dhabi, was the first volunteer to receive the jab. Others have since joined the trial.
It is one of dozens of vaccines in development against Covid-19. It's a great work by Abu Dhabi 👏👏
Comments
Post a Comment